Massachusetts Institute of Technology
Sign in Create Account

The David H. Koch Institute for Integrative Cancer Research @MIT

The Koch Institute

The David H. Koch Institute for Integrative Cancer Research at MIT both transforms and transcends the MIT Center for Cancer Research (CCR). Founded in 1974 by Nobel Laureate and MIT Professor Salvador Luria, CCR has made enormous contributions to the field of cancer research, including:

  • Identified the molecules that led to two of the first FDA-approved molecularly targeted anti-cancer drugs: Herceptin® (1998) and Gleevec® (2001)
  • Isolated the first human cancer genes
  • Discovered extracellular matrix components and their receptors, which play a critical role in metastasis
  • Contributed to the sequencing of the human genome
  • Developed novel materials for sustained delivery of anti-cancer drugs

CCR/Koch remains one of only eight National Cancer Institute-designated basic research centers in the US. And our faculty have earned the most prestigious national and international science honors:

  • Five current and former faculty have been awarded the Nobel Prize
  • 14 current faculty are members of the National Academy of Sciences
  • Six current and former faculty have been awarded the National Medal of Science
  • Five current faculty are Howard Hughes Medical Institute Investigators

Collection videos

One-on-One: Linnea Duff & Anna Farago

One-on-One: Linnea Duff & Anna Farago

Added 1 year ago | 00:59:38 | 600 views

Join us for an inspirational special event featuring cancer patient and advocate Linnea Duff and thoracic oncologist and Koch Institute postdoctoral researcher Anna Farago in an intimate conversation about the powerful impact cancer rese...

SOLUTIONS with/in/sight: Women on the Front Lines in the Fight Against Cancer

SOLUTIONS with/in/sight: Women on t...

Added over 1 year ago | 01:21:59 | 779 views

October 29, 2013, 6:00 p.m. Bringing together leaders in research, industry, clinical care, and patient advocacy, this program showcases bold approaches to fight cancer. Biocon CEO Kiran Mazumder-Shaw went from brewer to biotechnology ic...

2009 Koch Institute Symposium -  Ann Chambers

2009 Koch Institute Symposium - An...

Added almost 6 years ago | 00:24:52 | 29903 views

2009 Koch Institute Symposium Ann Chambers: "Monitoring the Fate of Cancer Cells During Metastasis"

SOLUTIONS with/in/sight: Understanding the Path to Personalized Cancer Care

SOLUTIONS with/in/sight: Understand...

Added 2 years ago | 01:10:27 | 1512 views

This with/in/sight program on November 7, 2012, featured three experts exploring the future of cancer diagnostics and treatments that are personlaized to the unique attributes of each patient and their cancer.  Nikhil Munshi, multip...

Douglas Lauffenburger

Douglas Lauffenburger

Added over 2 years ago | 00:30:05 | 984 views

Recorded 11/6/12

See all 139 videos

Collection details




You can have new episodes delivered directly to your computer as soon as they’re available.